+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colorectal Cancer Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 146 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5563117
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The colorectal cancer therapeutics market is forecasted to grow by USD 2.00 billion during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the colorectal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, rising occurrence of colorectal cancer, and introduction of combination therapeutics.

The colorectal cancertherapeutics market is segmented as below:

By Type

  • Targeted therapy
  • Immunotherapy
  • Chemotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the development of small molecule kinase inhibitors as one of the prime reasons driving the colorectal cancer therapeutics market growth during the next few years. Also, advent of gene therapy and personalized therapeutics will lead to sizable demand in the market.

The report on the colorectal cancer therapeutics market covers the following areas:

  • Colorectal cancer therapeutics market sizing
  • Colorectal cancer therapeutics market forecast
  • Colorectal cancer therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading colorectal cancer therapeutics market vendors that include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals PLC, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the colorectal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Colorectal Cancer Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Targeted therapy - Market size and forecast 2023-2028
Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
6.4 Immunotherapy - Market size and forecast 2023-2028
Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
6.5 Chemotherapy - Market size and forecast 2023-2028
Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
11.5 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.9 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
11.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Type ($ million)
Exhibits 47: Data Table on Market opportunity by Type ($ million)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: Amgen Inc. - Overview
Exhibits 98: Amgen Inc. - Product / Service
Exhibits 99: Amgen Inc. - Key news
Exhibits 100: Amgen Inc. - Key offerings
Exhibits 101: Bayer AG - Overview
Exhibits 102: Bayer AG - Business segments
Exhibits 103: Bayer AG - Key news
Exhibits 104: Bayer AG - Key offerings
Exhibits 105: Bayer AG - Segment focus
Exhibits 106: Biocon Ltd. - Overview
Exhibits 107: Biocon Ltd. - Business segments
Exhibits 108: Biocon Ltd. - Key offerings
Exhibits 109: Biocon Ltd. - Segment focus
Exhibits 110: Bristol Myers Squibb Co. - Overview
Exhibits 111: Bristol Myers Squibb Co. - Product / Service
Exhibits 112: Bristol Myers Squibb Co. - Key news
Exhibits 113: Bristol Myers Squibb Co. - Key offerings
Exhibits 114: Eli Lilly and Co. - Overview
Exhibits 115: Eli Lilly and Co. - Product / Service
Exhibits 116: Eli Lilly and Co. - Key news
Exhibits 117: Eli Lilly and Co. - Key offerings
Exhibits 118: F. Hoffmann La Roche Ltd. - Overview
Exhibits 119: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 120: F. Hoffmann La Roche Ltd. - Key news
Exhibits 121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 122: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 123: Fresenius SE and Co. KGaA - Overview
Exhibits 124: Fresenius SE and Co. KGaA - Business segments
Exhibits 125: Fresenius SE and Co. KGaA - Key news
Exhibits 126: Fresenius SE and Co. KGaA - Key offerings
Exhibits 127: Fresenius SE and Co. KGaA - Segment focus
Exhibits 128: Merck and Co. Inc. - Overview
Exhibits 129: Merck and Co. Inc. - Business segments
Exhibits 130: Merck and Co. Inc. - Key news
Exhibits 131: Merck and Co. Inc. - Key offerings
Exhibits 132: Merck and Co. Inc. - Segment focus
Exhibits 133: Sanofi SA - Overview
Exhibits 134: Sanofi SA - Business segments
Exhibits 135: Sanofi SA - Key news
Exhibits 136: Sanofi SA - Key offerings
Exhibits 137: Sanofi SA - Segment focus
Exhibits 138: Viatris Inc. - Overview
Exhibits 139: Viatris Inc. - Business segments
Exhibits 140: Viatris Inc. - Key news
Exhibits 141: Viatris Inc. - Key offerings
Exhibits 142: Viatris Inc. - Segment focus
Exhibits 143: Inclusions checklist
Exhibits 144: Exclusions checklist
Exhibits 145: Currency conversion rates for US$
Exhibits 146: Research methodology
Exhibits 147: Information sources
Exhibits 148: Data validation
Exhibits 149: Validation techniques employed for market sizing
Exhibits 150: Data synthesis
Exhibits 151: 360 degree market analysis
Exhibits 152: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global colorectal cancer therapeutics market: Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of small molecule kinase inhibitors."

According to the report, one of the major drivers for this market is the increasing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accord Healthcare Ltd.
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Biocon Ltd.
  • Bristol Myers Squibb Co.
  • CK Hutchison Holdings Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • Hetero Drugs Ltd.
  • Hikma Pharmaceuticals Plc
  • Merck and Co. Inc.
  • Ono Pharmaceutical Co. Ltd.
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Colorectal Cancer Drugs Global Market Report 2024 - Product Image

Colorectal Cancer Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Colorectal Cancer Drugs Market by Drug Class, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Drugs Market by Drug Class, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Colorectal Cancer Therapeutics Market Analysis & Forecast to 2024-2034 - Product Image

Colorectal Cancer Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 172 Pages
  • Global
From
Colorectal Cancer Therapeutics - Global Strategic Business Report - Product Image

Colorectal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.